Cohen Klingenstein LLC Bristol Myers Squibb CO Transaction History
Cohen Klingenstein LLC
- $2.76 Billion
- Q3 2024
A detailed history of Cohen Klingenstein LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cohen Klingenstein LLC holds 68,559 shares of BMY stock, worth $3.8 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
68,559
Previous 69,400
1.21%
Holding current value
$3.8 Million
Previous $2.88 Million
23.07%
% of portfolio
0.13%
Previous 0.11%
Shares
6 transactions
Others Institutions Holding BMY
# of Institutions
2,453Shares Held
1.5BCall Options Held
29.6MPut Options Held
32.1M-
Vanguard Group Inc Valley Forge, PA187MShares$10.3 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.8 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$5.07 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$4.14 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.27 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $118B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...